These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12151391)
21. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827 [TBL] [Abstract][Full Text] [Related]
22. Expression of biologically active human vascular endothelial growth factor in yeast. Mohanraj D; Olson T; Ramakrishnan S Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160 [TBL] [Abstract][Full Text] [Related]
23. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172 [TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and angiogenic activity of endothelial cells: direct or VEGF-dependent effect? Dulak J; Józkowicz A Cardiovasc Res; 2002 Dec; 56(3):487-8; author reply 489-91. PubMed ID: 12445890 [No Abstract] [Full Text] [Related]
25. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Fiebich BL; Jäger B; Schöllmann C; Weindel K; Wilting J; Kochs G; Marmé D; Hug H; Weich HA Eur J Biochem; 1993 Jan; 211(1-2):19-26. PubMed ID: 7678805 [TBL] [Abstract][Full Text] [Related]
26. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. Zilberberg L; Shinkaruk S; Lequin O; Rousseau B; Hagedorn M; Costa F; Caronzolo D; Balke M; Canron X; Convert O; Laïn G; Gionnet K; Goncalvès M; Bayle M; Bello L; Chassaing G; Deleris G; Bikfalvi A J Biol Chem; 2003 Sep; 278(37):35564-73. PubMed ID: 12837752 [TBL] [Abstract][Full Text] [Related]
27. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface. Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694 [TBL] [Abstract][Full Text] [Related]
28. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088 [TBL] [Abstract][Full Text] [Related]
29. Selective functions of angiopoietins and vascular endothelial growth factor on blood vessels: the concept of "vascular domain". Sato TN; Loughna S; Davis EC; Visconti RP; Richardson CD Cold Spring Harb Symp Quant Biol; 2002; 67():171-80. PubMed ID: 12858538 [No Abstract] [Full Text] [Related]
30. [Role of VEGF in the cellular response to injury]. Alvarez-Arroyo MV; Yagüe S; González-Pacheco FR; Castilla MA; Suzuki Y; Jiménez S; Deudero JJ; Neria F; Velasco L; Caramelo C Nefrologia; 2003; 23 Suppl 3():54-7. PubMed ID: 12901194 [No Abstract] [Full Text] [Related]
33. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Pintucci G; Froum S; Pinnell J; Mignatti P; Rafii S; Green D Thromb Haemost; 2002 Nov; 88(5):834-42. PubMed ID: 12428103 [TBL] [Abstract][Full Text] [Related]
34. [Mechanisms and role of lymphangiogenesis in cancer metastasis]. Dupuy E; Tobelem G Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800 [TBL] [Abstract][Full Text] [Related]
35. New gene therapy for the treatment of burn wounds. Guarini S Crit Care Med; 2003 Apr; 31(4):1280-1. PubMed ID: 12682507 [No Abstract] [Full Text] [Related]
36. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193 [TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor: molecular and biological aspects. Ferrara N Curr Top Microbiol Immunol; 1999; 237():1-30. PubMed ID: 9893343 [No Abstract] [Full Text] [Related]
38. A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts. Coles LS; Diamond P; Lambrusco L; Hunter J; Burrows J; Vadas MA; Goodall GJ Nucleic Acids Res; 2002 Nov; 30(22):4845-54. PubMed ID: 12433987 [TBL] [Abstract][Full Text] [Related]